Deutsche Bank downgraded stock and Needham cut price targets citing safety concerns regarding Xenon's product ahead of its NDA meeting.
1 report, 1 independent
Updated Sep 21
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Deutsche Bank downgraded stock and Needham cut price targets citing safety concerns regarding Xenon's product ahead of its NDA meeting.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Xenon
nightclub in New York City
Nothing else this week.
-
Deutsche Bank
German global banking and financial services company
Related events
- Deutsche Bank downgraded Lennox International Inc. stock to Hold on September 14, 2026.
- Deutsche Bank reiterated a buy rating and price objective, while Citigroup and Jefferies Financial Group issued buy ratings and price targets for an unnamed company.
- Spyre Therapeutics, Inc. was listed on Nasdaq and received analyst ratings from firms including Deutsche Bank and Stifel.
- Stifel reiterated a Buy rating and target price for Spyre Therapeutics, while Deutsche Bank lowered targets following company results.